Skip to main content
. Author manuscript; available in PMC: 2013 Nov 13.
Published in final edited form as: Int J Obes (Lond). 2011 Oct 11;36(6):10.1038/ijo.2011.197. doi: 10.1038/ijo.2011.197

Table 1.

Baseline Subject Characteristics

Variable Placebo Vitamin D p-value
N 18 19 -
Men/Womena 6/12 7/12 0.593
Age (yrs) 31.9 ± 10.3 31.1 ± 10.0 0.799
Height (cm) 1.70 ± 0.1 1.70± 0.1 0.988
Weight (kg) 87.2 ± 21.9 85.6 ± 25.4 0.846
BMI (kg/m2) 30.4 ± 7.7 29.9 ± 8.9 0.844
SBP (mmHg) 121.2 ± 13.9 124.9 ± 18.4 0.500
DBP (mmHg) 74.1 ± 10.8 74.8 ± 10.1 0.852
Total cholesterol (mg/dL) 161.7 + 56.1 135.5 ± 29.5 0.090
HDL (mg/dL) 46.4 ± 15.2 55.2 ± 16.9 0.108
LDL (mg/dL) 121.4 ± 58.0 67.6 ± 28.1 0.006
Triglycerides (mg/dL) 83.5 ± 27.4 72.6 ± 21.6 0.194
HbA1c (mg/dL) 5.5 ± 0.5 5.4 ± 0.5 0.553
25 (OH)D (nmol/L) 40.7±15.7 35.4±11.3 0.249
Telomerase activity (AU) 1.43±0.26 1.56±0.29 0.146

Values are mean ± SD. All results not marked were based on independent t test.

a

Test of significance between groups were based on Fisher’s exact test.

Abbreviations: BMI, Body mass index; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; HDL, High density lipo-protein; LDL, Low density lipo-protein; HbA1c, Hemoglobin A1c.